Caihong Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Caihong Hu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Biaobiao Wang
Department of Obstetrics, Xiangya Hospital Central South University, Changsha, China
2 shared publicationsMingyue Guo
Department of Obstetrics, Xiangya Hospital Central South University, Changsha, China
2 shared publicationsQi Li
Reproductive Medicine Center, Xiangya Hospital Central South University, Changsha, China
2 shared publicationsQi Wang
Department of Obstetrics, Xiangya Hospital Central South University, Changsha, China
2 shared publicationsRuohan Wang
Department of Obstetrics, Xiangya Hospital Central South University, Changsha, China
2 shared publicationsWeishe Zhang
Department of Obstetrics, Xiangya Hospital Central South University, Changsha, China
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature in Systematic Reviews
Evaluation of fetal growth restriction guidelines using the AGREE II, STAR, and RIGHT tools
- 22 October 2026
- Published by Springer Nature in Systematic Reviews
Open AccessEvaluation of fetal growth restriction guidelines using the AGREE II, STAR, and RIGHT tools
- Open Access
- 14 January 2026
- Published by Springer Nature in Research Square
Evaluation of fetal growth restriction guidelines Based on AGREE II, STAR and RIGHT Tools
Objectives To comprehensively evaluate the quality of guidelines related to fetal growth restriction(FGR), with a view to provide recommendations for the development of high-quality guidelines. Methods CNKI, Wanfang, Chinese Medical journal, PubMed, Embase, Web of Science and other databases were searched for FGR guidelines published from database establishment to September, 2024. Used the Appraisal of Guidelines for Research and Evaluation II(AGREEII)instrument, the Reporting Items for practice Guidelines in Health care (RIGHT) checklist and Scientific, Transparent and Applicable Rankings (STAR) tool to assess the quality of guidelines. We tested the consistency of the evaluation results of researchers by calculating the intraclass correlation coefficient (ICC). Results A total of 10 guidelines were included in this study, including nine English CPGs and one Chinese CPG. According to the AGREE II instrument, two CPGs were “recommended,” while eight were “suggested with modifications”. STAR tool results showed scores of 0.00%, 0.00%, 26.41%, 18.49%, 38.28%, 55.85%, 62.55%, 26.54%, 88.66%, 27.54%, and 70.00% for registry, protocol, funding, guideline development groups, conflicts of interest, clinical questions, evidence, consensus method, recommendations, accessibility, and other aspects, respectively. RIGHT checklist reporting rates were 76.67% (basic information), 66.25% (background), 68.00% (evidence), 68.57% (recommendations), 70.00% (review and quality assurance), 40.00% (funding and declaration and management of interests), and 73.34% (other information). Conclusions The quality of FGR guidelines still needs to be further improved. It is recommended that future guideline development and updates should pay more attention to clarifying the target populations and settings of guideline use. Guideline authors should involve experts in statistics and guideline methodology to enhance the quality of evidence supporting the guidelines. Additionally, the influencing factors during guideline dissemination to clinical practice, as well as the practical implementation of guidelines in clinical settings, should be considered more comprehensively. Furthermore, the independence of guideline development, including the management of conflicts of interest and funding issues, also requires improvement.
- 14 January 2026
- Published by Springer Nature in Research Square
Open AccessEvaluation of fetal growth restriction guidelines Based on AGREE II, STAR and RIGHT Tools
Objectives To comprehensively evaluate the quality of guidelines related to fetal growth restriction(FGR), with a view to provide recommendations for the development of high-quality guidelines. Methods CNKI, Wanfang, Chinese Medical journal, PubMed, Embase, Web of Science and other databases were searched for FGR guidelines published from database establishment to September, 2024. Used the Appraisal of Guidelines for Research and Evaluation II(AGREEII)instrument, the Reporting Items for practice Guidelines in Health care (RIGHT) checklist and Scientific, Transparent and Applicable Rankings (STAR) tool to assess the quality of guidelines. We tested the consistency of the evaluation results of researchers by calculating the intraclass correlation coefficient (ICC). Results A total of 10 guidelines were included in this study, including nine English CPGs and one Chinese CPG. According to the AGREE II instrument, two CPGs were “recommended,” while eight were “suggested with modifications”. STAR tool results showed scores of 0.00%, 0.00%, 26.41%, 18.49%, 38.28%, 55.85%, 62.55%, 26.54%, 88.66%, 27.54%, and 70.00% for registry, protocol, funding, guideline development groups, conflicts of interest, clinical questions, evidence, consensus method, recommendations, accessibility, and other aspects, respectively. RIGHT checklist reporting rates were 76.67% (basic information), 66.25% (background), 68.00% (evidence), 68.57% (recommendations), 70.00% (review and quality assurance), 40.00% (funding and declaration and management of interests), and 73.34% (other information). Conclusions The quality of FGR guidelines still needs to be further improved. It is recommended that future guideline development and updates should pay more attention to clarifying the target populations and settings of guideline use. Guideline authors should involve experts in statistics and guideline methodology to enhance the quality of evidence supporting the guidelines. Additionally, the influencing factors during guideline dissemination to clinical practice, as well as the practical implementation of guidelines in clinical settings, should be considered more comprehensively. Furthermore, the independence of guideline development, including the management of conflicts of interest and funding issues, also requires improvement.
- Open Access
- 27 February 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (3) , 299
3D Printing and Its Current Status of Application in Obstetrics and Gynecological Diseases
3D printing technology is a novel method of utilizing computer-generated three-dimensional models for drawing, assembling special bioinks, and manufacturing artificial organs and biomedical products. In recent years, it has evolved into a relatively mature therapeutic approach and has been widely used in clinical and basic research. In the field of obstetrics and gynecology, 3D printing technology has been applied for various purposes, including disease diagnosis, treatment, pathogenesis research, and medical education. Notably, researchers have gained significant application experience in common gynecological and obstetrical disorders, such as intrauterine adhesions, uterine tumors, congenital malformations, and fetal congenital abnormalities. This review aims to provide a systematical summary of current research on the application of 3D bioprinting technology in the field of obstetrics and gynecology.
- 27 February 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (3) , 299
Open Access3D Printing and Its Current Status of Application in Obstetrics and Gynecological Diseases
3D printing technology is a novel method of utilizing computer-generated three-dimensional models for drawing, assembling special bioinks, and manufacturing artificial organs and biomedical products. In recent years, it has evolved into a relatively mature therapeutic approach and has been widely used in clinical and basic research. In the field of obstetrics and gynecology, 3D printing technology has been applied for various purposes, including disease diagnosis, treatment, pathogenesis research, and medical education. Notably, researchers have gained significant application experience in common gynecological and obstetrical disorders, such as intrauterine adhesions, uterine tumors, congenital malformations, and fetal congenital abnormalities. This review aims to provide a systematical summary of current research on the application of 3D bioprinting technology in the field of obstetrics and gynecology.